CHMP has granted Eisai Europe and Biogen a positive opinion for the use of their monoclonal antibody therapy in treating early Alzheimer’s disease.

Bitte informieren Sie sich nochmals vor Reiseantritt über Ihre Verbindung auf bahn.de, im DB Navigator oder bei der telefonischen Reiseauskunft 030/2970." Diese Meldung wurde am 08.01.2025 um 15.07 ...

Das Unternehmen teilt dazu mit: "Aufgrund einer Reparatur an der Weiche zwischen Köln und Wuppertal kommt es derzeit zu Beeinträchtigungen im Fernverkehr der Deutschen Bahn. Dadurch kommt es zu ...

JPMorgan upgraded Wuxi Biologics (WXXWY) to Overweight from Neutral with a price target of HK$20, up from HK$13, citing expected order growth and improved margins. Although the newsthat WuXi Bio ...

Wuxi Biologics (WXXWY) plans to sell its Irish vaccine facility to Merck (MRK) for around $500M ahead of potential U.S. legislation that would limit business for Chinese biotech companies ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

SHANGHAI and SAN DIEGO, Jan. 6, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced an ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Image credit: Shutterstock / CI Photos. US-based Candid Therapeutics has signed another T-cell engager (TCE) partnership, this time with Chinese biotech WuXi Biologics for the global rights to a ...